Related Experiment Video
Updated: Jun 27, 2026
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Gene-based bin analysis of genome-wide association studies
Nicolas Omont1, Karl Forner, Marc Lamarine
1Merck Serono International S,A, 9 chemin des Mines, 1202 Geneva, Switzerland.
BMC Proceedings
|December 19, 2008
Summary
New analytical methods are crucial for genome-wide association studies (GWAS) due to increasing data. This study introduces a Bayesian approach to effectively analyze GWAS results, overcoming scale-up challenges and identifying disease-associated regions.
Area of Science:
- Genomics
- Statistical Genetics
- Computational Biology
Background:
- Genome-wide association studies (GWAS) are vital for complex disease research.
- Increasing marker numbers necessitate advanced analytical methods for GWAS.
- Challenges include multiple testing, data quality control, and computational efficiency.
Purpose of the Study:
- To develop a novel analytical method for genome-wide association studies.
- To address the challenges posed by large-scale genomic data in association studies.
- To improve the identification of statistically significant genomic regions associated with complex diseases.
Main Methods:
- A Bayesian model integrating genotyping errors and genomic structure.
- Assigning p-values to genomic regions (bins) based on gene-biased partitioning.
- Estimating the false-discovery rate for robust statistical inference.
Main Results:
- The novel method effectively handles the scale-up issues in GWAS.
- Application to Multiple Sclerosis GWAS data demonstrated the algorithm's utility.
- Identification of new putative genomic regions statistically linked to the disease.
Conclusions:
- The developed method overcomes practical scale-up problems in GWAS analysis.
- It enables the identification of novel genomic regions associated with complex diseases.
- This approach enhances the power of GWAS for genetic discovery.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
02:54Evolutionary Relationships through Genome Comparisons
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...